StockWatch
·
Filing
Q2

Sagility India Ltd

SAGILITYFY2629 Oct 2025
Revenue+7.8%
Net Profit+68.8%
OPM25.03%

P&L

Quarterly Consolidated

Revenue
+7.8%1.7K
Expenditure
+3.8%1.4K
Net Profit
+68.8%250.83
NPM 14.61%+52.4%EPS ₹0.53+65.6%

vs Q1 FY26

Sagility Ltd Reports 25.2% YoY Revenue Growth in Q2FY26 & H1 FY26 Consolidated)

29 Oct 2025 · 29 Oct 2025, 07:33 pm

Summary

Sagility Ltd, a leading global provider of technology-enabled business solutions and services to clients in the U.S healthcare Industry, reported its consolidated financial results for the quarter ended Sep 30, 2025. The company reported a YoY revenue growth of 25.2% (20.0% in CC terms), Adjusted EBITDA at 26.2% with 25.6% YoY growth, and Adjusted PAT at 18.1% with 84.0% YoY growth.

Key Highlights

  1. 1

    Revenue at INR 21,658 million (US$ 189.4 million), YoY growth of 25.2% (20.0% in CC terms)

  2. 2

    Organic YoY growth of 16.0% (11.1% in CC terms)

  3. 3

    Adjusted EBITDA at INR 4,352 million (USS 49.8 million) at 26.2% of revenue, YoY growth of 25.6%

  4. 4

    Adjusted PAT at INR 3,010 million (US$ 34.5 million) at 18.1% of revenue, YoY growth of 84.0%

  5. 5

    Interim Dividend of INR 0.05 per share

  6. 6

    44,185 employees

  7. 7

    Presence in 5 countries with 34 delivery centers

  8. 8

    Awarded Great Place to Work-Certified™ in India in Sept 2025

  9. 9

    Winner of the Asia CEO Awards 2025 - “Service Excellence Company of the Year” for Sagility Philippines

Management Comments

R

Ramesh Gopalan

Managing Director and Group CEO

Our performance through the first half of FY26 underscores Sagility’s ability to sustain a healthy growth in a changing marketplace. As our clients continue to deal with profitability pressures, we are bringing our domain expertise and transformational capabilities to help them reduce cost of operations.

S

Sarvabhouman Srinivasan

Group Chief Financial Officer

Our margin profile continues to be robust, alongside strong growth. This is a result of disciplined cost management initiatives and operational efficiencies. We continue to generate strong operating cash flows and maintain a healthy balance sheet while progressively lowering debt. We will continue to invest in driving growth, further strengthening our technology and AI capabilities, and building an AI-ready healthcare-centric future workforce.

Informational and educational content only. Not investment advice.